• 'Found in the Dark'

    The Impact of Drug Law Enforcement Practices in Myanmar
    Ernestien Jensema & Nang Pann Ei Kham
    Drug Policy Briefing Nr. 47
    September 2016

    To address its serious drug use problems, Myanmar should change its drug policy towards a harm reduction approach. Instead of a repressive approach, voluntary and evidence-based treatment and public health services, including harm reduction, should be made available and become generally accepted by enforcement officials and by the community at large. Myanmar has very strict drug laws and policies, and its legal framework emphasises harsh sentences and the criminalisation of drug users rather than providing access to health and harm reduction services. This report highlights the impact of current drug law enforcement practices in Myanmar and illustrates why a change in drug legislation and policy is necessary.

    Download the report (PDF)

    READ MORE...
  • Paraguay: The cannabis breadbasket of the Southern Cone

    A focus on the largest cannabis producer in South America
    Guillermo Garat
    Drug Policy Briefing Nr. 46
    July 2016

    Paraguay is the principal producer of cannabis in South America, though nobody knows for certain how many hectares are planted with this crop, probably on account of its concealment and a prevalent climate of corruption. National authorities and international control agencies estimate an area between 6,000 and 7,000 hectares, with an annual production of 16,500 tonnes. At present, according to estimates of the Paraguayan National Anti-Drug Secretariat (Secretaría Nacional Anti Drogas - SENAD), some 20,000 farmers are involved in cannabis cultivation, boosting the microeconomy of the north-eastern region of the country.

    application-pdfDownload the briefing (PDF)

    READ MORE...
  • UNGASS 2016: A Broken or B-r-o-a-d Consensus?

    UN summit cannot hide a growing divergence in the global drug policy landscape
    Dave Bewley-Taylor Martin Jelsma
    Drug Policy Briefing Nr 45
    July 2016

    A special session of the General Assembly took place in April revealing a growing divergence in the global drug policy landscape. Difficult negotiations resulted in a disappointing outcome document, perpetuating a siloed approach to drugs at the UN level. There is a clear need to realign international drug policies with the overarching 2030 Agenda and the Sustainable Development Goals, embedding the drugs issue comprehensively within the UN’s three pillars: development, human rights, and peace and security. The UNGASS process has helped to set the stage for more substantial changes in the near future, towards the next UN review in 2019.

    application-pdfDownload the briefing (PDF)

    READ MORE...
  • Cannabis in Indonesia

    Patterns in consumption, production, and policies
    Dania Putri Tom Blickman
    Drug Policy Briefing Nr 44
    January 2016

    Cannabis use has never posed major problems in Indonesia, yet prohibitionist policies prevail. Despite the high prevalence of cannabis use, local or national discussions on cannabis policies are nearly non-existent, exacerbated by strong anti-drug views and public institutions' failure to design and implement comprehensive policies based on evidence. Because of the current anti-narcotics law – discussed in detail in this briefing – there have been many obstacles to research on cannabis, both in terms of medical and anthropological research.

    application-pdfDownload the briefing (PDF)

    READ MORE...
  • Ayahuasca: From the Amazon to the Global Village

    An analysis of the challenges associated with the globalisation of ayahuasca
    Constanza Sánchez & José Carlos Bouso
    Drug Policy Briefing Nr. 43
    December 2015

    Indigenous peoples in the Amazon have used ayahuasca for centuries as a remedy for physical and psychological health, and to ensure the life and wellbeing of their communities. In the past two decades, the use of this decoction has expanded beyond Amazon indigenous spheres. Globalisation, and with it the contact between populations, has facilitated cultural exchange between indigenous traditions and Western practices, which has led to a growing interest in the ritual, religious and therapeutic use of ayahuasca.

    application-pdfDownload the briefing (PDF)

  • The UN and Harm Reduction - Revisited

    An unauthorised report on the outcomes of the 48th CND session
    Martin Jelsma
    TNI Drug Policy Briefing Nr. 13
    April 2005
     

    The US pressure on the UNODC to withdraw support from needle exchange and other harm reduction approaches backfired at the 48th session of the CND in March 2005. Delegates from around the globe stood up to defend the overwhelming evidence that harm reduction measures are effective against the spread of HIV/AIDS. In this briefing TNI analyses the proceedings and results of the CND meeting in Vienna in March 2005, and outlines several options for follow-up and recommends next steps to take.

    application-pdfDownload the briefing (PDF)

    READ MORE...
  • The United Nations and Harm Reduction

    Martin Jelsma
    TNI Drug Policy Briefing Nr. 12
    March 2005

    In March 2005 the UN Commission on Narcotic Drugs (CND) will meet in Vienna. The confrontation between zero-tolerance ideologists and harm reduction pragmatists will be fiercer than ever before. The US government – the biggest donor of UNODC – threatened to cut funding to UNODC unless the agency assured that it would abstain from any support for harm reduction, including needle exchange programmes and substitution treatment. Conflicting views within the UN system on harm reduction have become a major concern. Consistency in messages is crucial especially where it concerns joint global programmes such as the efforts to slow down the HIV/AIDS epidemic.

    Download the briefing (PDF)

    READ MORE...